Related Experiment Videos

Daily hemodialysis: the time has come?--Con

Gerald Schulman¹

¹Department of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation

|April 30, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Clinical and experimental nephrology·2017

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

BMC nephrology·2016

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

Journal of the American Society of Nephrology : JASN·2014

Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Journal of the American Society of Nephrology : JASN·2014

AST-120 for the management of progression of chronic kidney disease.

International journal of nephrology and renovascular disease·2014

Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2013

See all related articles